531752 — Biogen Pharmachem Industries Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹743.97m
- IN₹798.78m
- 21
- 28
- 66
- 28
Annual cashflow statement for Biogen Pharmachem Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.035 | -1.17 | -16 | -0.086 | 4.55 |
| Depreciation | |||||
| Changes in Working Capital | 0.911 | -11 | 55.5 | 14.1 | 12.5 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.875 | -12.1 | 39.5 | 14 | 17 |
| Other Investing Cash Flow Items | -7.24 | 15.4 | -36.4 | -13.2 | -16.6 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -7.24 | 15.4 | -36.4 | -13.2 | -16.6 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.18 | -3.24 | -3.06 | 0 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.186 | 0.003 | 0.041 | 0.757 | 0.455 |